Neonatal hyperinsulinism: a retrospective study of presentation and management in a tertiary neonatal intensive care unit in the UK.

Maria-Sofia Kalogeropoulou, Helen Couch, Ajay Thankamony, Kathy Beardsall
{"title":"Neonatal hyperinsulinism: a retrospective study of presentation and management in a tertiary neonatal intensive care unit in the UK.","authors":"Maria-Sofia Kalogeropoulou, Helen Couch, Ajay Thankamony, Kathy Beardsall","doi":"10.1136/archdischild-2024-327322","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Reports of hyperinsulinism typically focus on infants managed by highly specialised services. However, neonates with hyperinsulinism are initially managed by neonatologists and often not referred to specialists. This study aimed to characterise the diversity in presentation and management of these infants.</p><p><strong>Setting: </strong>Level 3 neonatal intensive care.</p><p><strong>Patients: </strong>Neonates with hyperinsulinism, defined as blood glucose <2.8 mmol/mL and insulin level >6 pmol/L.</p><p><strong>Design: </strong>7-year retrospective study (January 2015-December 2021).</p><p><strong>Results: </strong>99 cases were identified: <i>severe</i>-treated with diazoxide (20%), <i>moderate</i>-clinically concerning hyperinsulinism not treated with diazoxide (30%), <i>mild</i>-biochemical hyperinsulinism (50%). Birth weight z-score was -1.02±2.30 (mean±SD), 42% were preterm, but neither variable correlated with clinical severity. The <i>severe</i> group received a higher concentration of intravenous glucose (27±12%) compared with the <i>moderate</i> (15±7%) and <i>mild</i> (16±10%) groups (p<0.001). At diagnosis, the intravenous glucose intake was similar in the <i>severe</i> (7.43±5.95 mg/kg/min) and <i>moderate</i> (5.09±3.86 mg/kg/min) groups, but higher compared with the <i>mild</i> group (3.05+/2.21 mg/kg/min) (p<0.001). In the <i>severe</i> group, term infants started diazoxide earlier (9.9±4.3 days) compared with preterm (37±26 days) (p=0.002). The national congenital hyperinsulinism service was consulted for 23% of infants, and 3% were transferred.</p><p><strong>Conclusions: </strong>This study highlights the diversity in clinical presentation, severity and prognosis of neonatal hyperinsulinism, irrespective of birth weight and gestational age. More infants were small rather than large for gestational age, and the majority had transient hyperinsulinism and were not referred to the national centre, or treated with diazoxide. Further research is required to understand the breadth of neonatal hyperinsulinism and optimal management.</p>","PeriodicalId":8177,"journal":{"name":"Archives of Disease in Childhood - Fetal and Neonatal Edition","volume":null,"pages":null},"PeriodicalIF":3.9000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Disease in Childhood - Fetal and Neonatal Edition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/archdischild-2024-327322","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Reports of hyperinsulinism typically focus on infants managed by highly specialised services. However, neonates with hyperinsulinism are initially managed by neonatologists and often not referred to specialists. This study aimed to characterise the diversity in presentation and management of these infants.

Setting: Level 3 neonatal intensive care.

Patients: Neonates with hyperinsulinism, defined as blood glucose <2.8 mmol/mL and insulin level >6 pmol/L.

Design: 7-year retrospective study (January 2015-December 2021).

Results: 99 cases were identified: severe-treated with diazoxide (20%), moderate-clinically concerning hyperinsulinism not treated with diazoxide (30%), mild-biochemical hyperinsulinism (50%). Birth weight z-score was -1.02±2.30 (mean±SD), 42% were preterm, but neither variable correlated with clinical severity. The severe group received a higher concentration of intravenous glucose (27±12%) compared with the moderate (15±7%) and mild (16±10%) groups (p<0.001). At diagnosis, the intravenous glucose intake was similar in the severe (7.43±5.95 mg/kg/min) and moderate (5.09±3.86 mg/kg/min) groups, but higher compared with the mild group (3.05+/2.21 mg/kg/min) (p<0.001). In the severe group, term infants started diazoxide earlier (9.9±4.3 days) compared with preterm (37±26 days) (p=0.002). The national congenital hyperinsulinism service was consulted for 23% of infants, and 3% were transferred.

Conclusions: This study highlights the diversity in clinical presentation, severity and prognosis of neonatal hyperinsulinism, irrespective of birth weight and gestational age. More infants were small rather than large for gestational age, and the majority had transient hyperinsulinism and were not referred to the national centre, or treated with diazoxide. Further research is required to understand the breadth of neonatal hyperinsulinism and optimal management.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新生儿高胰岛素血症:对英国一家三级新生儿重症监护病房的发病和管理情况的回顾性研究。
目的:有关高胰岛素血症的报道通常集中在由高度专业化服务机构管理的婴儿身上。然而,患有高胰岛素血症的新生儿最初由新生儿科医生管理,通常不会转诊至专科医生。本研究旨在了解这些婴儿的表现和管理的多样性:患者:患有高胰岛素血症的新生儿:设计:7 年回顾性研究(2015 年 1 月至 2021 年 12 月):结果:99 例病例中,重度高胰岛素血症已用双氮醇治疗(20%),中度高胰岛素血症未用双氮醇治疗(30%),轻度生化高胰岛素血症(50%)。出生体重 Z 值为-1.02±2.30(平均值±SD),42%为早产儿,但这两个变量均与临床严重程度无关。与中度组(15±7%)和轻度组(16±10%)相比,重度组静脉注射的葡萄糖浓度更高(27±12%)(重度组(7.43±5.95 mg/kg/min)和中度组(5.09±3.但与轻度组(3.05+/2.21 mg/kg/min)相比,重度组更高(psevere 组,与早产儿(37±26 天)相比,足月儿更早(9.9±4.3 天)开始服用双氮醇(P=0.002)。23%的婴儿咨询了国家先天性高胰岛素血症服务机构,3%的婴儿被转院:本研究强调了新生儿高胰岛素血症临床表现、严重程度和预后的多样性,与出生体重和胎龄无关。与胎龄相比,更多的婴儿是小婴儿而不是大婴儿,大多数婴儿患有一过性高胰岛素血症,没有转诊到国家中心,也没有接受双氮醇治疗。要了解新生儿高胰岛素血症的广泛性和最佳治疗方法,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.00
自引率
4.50%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Archives of Disease in Childhood is an international peer review journal that aims to keep paediatricians and others up to date with advances in the diagnosis and treatment of childhood diseases as well as advocacy issues such as child protection. It focuses on all aspects of child health and disease from the perinatal period (in the Fetal and Neonatal edition) through to adolescence. ADC includes original research reports, commentaries, reviews of clinical and policy issues, and evidence reports. Areas covered include: community child health, public health, epidemiology, acute paediatrics, advocacy, and ethics.
期刊最新文献
Response to: 'Randomised crossover study on pulse oximeter readings from different sensors in very preterm infants' by Sharma et al. Clinical and neuroimaging patterns of perinatal intracranial haemorrhage in fetuses and term-born neonates: a prospective observational cohort study. Influence of clinical experience on newborn manikin mask ventilation performance using a respiratory function monitor. State of skin antiseptic choices in UK neonatal intensive care units in 2023. Associations between physical activity and development in preschool-aged children born <30 weeks' gestation: a cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1